Stock listing
OTC:GNBT Generex Biotechnology Corp Stock
Follow Generex Biotechnology Corp into a list and get an email when it puts out news.
Delisted OTC:GNBT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:GNBT
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Generex Biotechnology Corp on 6ix
- Decks
- 1 deck · latest Dec 4, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2018) | Investor deck | 17 slides | Dec 4, 2018 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Corrao Other companies: Apimeds Pharmaceuticals US, Inc. (Chief Financial Officer · Mar 4, 2025 – Mar 4, 2025 · Past); Amesite Inc. (Chief Financial Officer · Dec 15, 2021 – Dec 15, 2021 · Past); Neuropathix Inc (Chief Financial Officer · Mar 12, 2021 – Mar 12, 2021 · Past); Brain Scientific, Inc. (Chief Financial Officer · Oct 15, 2020 – Oct 15, 2020 · Past); Western Graphite Inc (CFO and Secretary, Director · Apr 1, 2015 – Apr 1, 2015 · Past) | CFO & Treasurer · Oct 3, 2018 – Oct 15, 2018 · Past |
| Richard David Purcell Jr Other companies: RespireRx Pharmaceuticals Inc (SVP - Research and Development · Mar 31, 2016 – Jul 31, 2020 · Past) | SVP Product Launch & Develop · Oct 3, 2018 – Oct 15, 2018 · Past |
| Andrew Ro | Chief Investment Officer & SVP, Director · Oct 3, 2018 – Oct 15, 2018 · Past |
| Gary Herbert Lyman | Director · Oct 3, 2018 – Oct 15, 2018 · Past |
| James H Anderson Jr | Director · Jun 8, 2011 – Oct 3, 2018 · Past |
| Mark Fletcher | EVP General Counsel &Secretary · Aug 17, 2007 – Oct 3, 2018 · Past |
| Mark Joseph SE Prioletti | Director · Jun 27, 2019 – Jun 27, 2019 · Past |
| Peter Amanatides | Director · May 30, 2006 – May 30, 2006 · Past |
Log in to ask 6ix AI your own questions about Generex Biotechnology Corp.